Global Gabapentin Market Size, Share, and COVID-19 Impact Analysis, By Type (Generic and Branded), By Dosage Form (Tablet, Capsule, and Oral Solution), By Application (Epilepsy, Neuropathic Pain, Restless Legs Syndrome, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033

Industry: Healthcare
RELEASE DATE Jan 2025
REPORT ID SI7788
PAGES 245
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis, By Type
      2. Market Attractiveness Analysis, By Dosage Form
      3. Market Attractiveness Analysis, By Application
      4. Market Attractiveness Analysis, By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Safer alternative to opioids in neuropathic pain
    3. Restraints
      1.  Side effects and increased competition from alternative therapies
    4. Opportunities
      1.  Improving healthcare infrastructure
    5. Challenges
      1. Intense competition from low-cost generic alternatives
  6. Global Gabapentin Market Analysis and Projection, By Type
    1. Segment Overview
    2. Generic
    3. Branded
  7. Global Gabapentin Market Analysis and Projection, By Dosage Form
    1. Segment Overview
    2. Tablet
    3. Capsule
    4. Oral Solution
  8. Global Gabapentin Market Analysis and Projection, By Application
    1. Segment Overview
    2. Epilepsy
    3. Neuropathic Pain
    4. Restless Legs Syndrome
    5. Others
  9. Global Gabapentin Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  10. Global Gabapentin Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Gabapentin Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  11. Company Profiles
    1. GLENMARK PHARMACEUTICALS LTD.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Arbor Pharmaceuticals, LLC 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Sun Pharmaceutical Industries Ltd. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Ascend Laboratories LLC 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   B.P. Pharma 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Zydus Lifesciences
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Teva Pharmaceutical Industries Ltd
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Amneal Pharmaceuticals LLC.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Cipla
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Apotex Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Assertio Holdings, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Aurobindo Pharma
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  Pfizer Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14.  Others
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Table

  1. Global Gabapentin Market, By Type, 2023-2033(USD Billion)
  2. Global Generic, Gabapentin Market, By Region, 2023-2033(USD Billion)
  3. Global Branded, Gabapentin Market, By Region, 2023-2033(USD Billion)
  4. Global Gabapentin Market, By Dosage Form, 2023-2033(USD Billion)
  5. Global Tablet, Gabapentin Market, By Region, 2023-2033(USD Billion)
  6. Global Capsule, Gabapentin Market, By Region, 2023-2033(USD Billion)
  7. Global Oral Solution, Gabapentin Market, By Region, 2023-2033(USD Billion)
  8. Global Gabapentin Market, By Application, 2023-2033(USD Billion)
  9. Global Epilepsy, Gabapentin Market, By Region, 2023-2033(USD Billion)
  10. Global Neuropathic Pain, Gabapentin Market, By Region, 2023-2033(USD Billion)
  11. Global Restless Legs Syndrome, Gabapentin Market, By Region, 2023-2033(USD Billion)
  12. Global Others, Gabapentin Market, By Region, 2023-2033(USD Billion)
  13. North America Gabapentin Market, By Type, 2023-2033(USD Billion)
  14. North America Gabapentin Market, By Dosage Form, 2023-2033(USD Billion)
  15. North America Gabapentin Market, By Application, 2023-2033(USD Billion)
  16. U.S.  Gabapentin Market, By Type, 2023-2033(USD Billion)
  17. U.S.  Gabapentin Market, By Dosage Form, 2023-2033(USD Billion)
  18. U.S.  Gabapentin Market, By Application, 2023-2033(USD Billion)
  19. Canada Gabapentin Market, By Type, 2023-2033(USD Billion)
  20. Canada Gabapentin Market, By Dosage Form, 2023-2033(USD Billion)
  21. Canada Gabapentin Market, By Application, 2023-2033(USD Billion)
  22. Mexico Gabapentin Market, By Type, 2023-2033(USD Billion)
  23. Mexico Gabapentin Market, By Dosage Form, 2023-2033(USD Billion)
  24. Mexico Gabapentin Market, By Application, 2023-2033(USD Billion)
  25. Europe Gabapentin Market, By Type, 2023-2033(USD Billion)
  26. Europe Gabapentin Market, By Dosage Form, 2023-2033(USD Billion)
  27. Europe Gabapentin Market, By Application, 2023-2033(USD Billion)
  28. Germany Gabapentin Market, By Type, 2023-2033(USD Billion)
  29. Germany Gabapentin Market, By Dosage Form, 2023-2033(USD Billion)
  30. Germany Gabapentin Market, By Application, 2023-2033(USD Billion)
  31. France Gabapentin Market, By Type, 2023-2033(USD Billion)
  32. France Gabapentin Market, By Dosage Form, 2023-2033(USD Billion)
  33. France Gabapentin Market, By Application, 2023-2033(USD Billion)
  34. U.K.  Gabapentin Market, By Type, 2023-2033(USD Billion)
  35. U.K.  Gabapentin Market, By Dosage Form, 2023-2033(USD Billion)
  36. U.K.  Gabapentin Market, By Application, 2023-2033(USD Billion)
  37. Italy Gabapentin Market, By Type, 2023-2033(USD Billion)
  38. Italy Gabapentin Market, By Dosage Form, 2023-2033(USD Billion)
  39. Italy Gabapentin Market, By Application, 2023-2033(USD Billion)
  40. Spain Gabapentin Market, By Type, 2023-2033(USD Billion)
  41. Spain Gabapentin Market, By Dosage Form, 2023-2033(USD Billion)
  42. Spain Gabapentin Market, By Application, 2023-2033(USD Billion)
  43. Asia Pacific Gabapentin Market, By Type, 2023-2033(USD Billion)
  44. Asia Pacific Gabapentin Market, By Dosage Form, 2023-2033(USD Billion)
  45. Asia Pacific Gabapentin Market, By Application, 2023-2033(USD Billion)
  46. Japan Gabapentin Market, By Type, 2023-2033(USD Billion)
  47. Japan Gabapentin Market, By Dosage Form, 2023-2033(USD Billion)
  48. Japan Gabapentin Market, By Application, 2023-2033(USD Billion)
  49. China Gabapentin Market, By Type, 2023-2033(USD Billion)
  50. China Gabapentin Market, By Dosage Form, 2023-2033(USD Billion)
  51. China Gabapentin Market, By Application, 2023-2033(USD Billion)
  52. India Gabapentin Market, By Type, 2023-2033(USD Billion)
  53. India Gabapentin Market, By Dosage Form, 2023-2033(USD Billion)
  54. India Gabapentin Market, By Application, 2023-2033(USD Billion)
  55. South America Gabapentin Market, By Type, 2023-2033(USD Billion)
  56. South America Gabapentin Market, By Dosage Form, 2023-2033(USD Billion)
  57. South America Gabapentin Market, By Application, 2023-2033(USD Billion)
  58. Brazil Gabapentin Market, By Type, 2023-2033(USD Billion)
  59. Brazil Gabapentin Market, By Dosage Form, 2023-2033(USD Billion)
  60. Brazil Gabapentin Market, By Application, 2023-2033(USD Billion)
  61. The Middle East and Africa Gabapentin Market, By Type, 2023-2033(USD   Billion)
  62. The Middle East and Africa Gabapentin Market, By Dosage Form, 2023-2033(USD   Billion)
  63. The Middle East and Africa Gabapentin Market, By Application, 2023-2033(USD Billion)
  64. UAE Gabapentin Market, By Type, 2023-2033(USD Billion)
  65. UAE Gabapentin Market, By Dosage Form, 2023-2033(USD Billion)
  66. UAE Gabapentin Market, By Application, 2023-2033(USD Billion)
  67. South Africa Gabapentin Market, By Type, 2023-2033(USD Billion)
  68. South Africa Gabapentin Market, By Dosage Form, 2023-2033(USD Billion)
  69. South Africa Gabapentin Market, By Application, 2023-2033(USD Billion)

 

List of Figures 

  1. Global Gabapentin Market Segmentation
  2. Gabapentin Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Gabapentin Market
  9. Top Winning Strategies, 2023-2033
  10. Top Winning Strategies, By Development, 2023-2033(%)
  11. Top Winning Strategies, By Company, 2023-2033
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2023
  18. Market Share Analysis, 2023
  19. Restraint and Drivers:  Gabapentin Market
  20. Gabapentin Market Segmentation, By Type
  21. Gabapentin Market For Generic, By Region, 2023-2033 ($ Billion)
  22.  Gabapentin Market For Branded, By Region, 2023-2033 ($ Billion)
  23.  Gabapentin Market Segmentation, By Dosage Form
  24.  Gabapentin Market For Tablet, By Region, 2023-2033 ($ Billion)
  25.  Gabapentin Market For Capsule, By Region, 2023-2033 ($ Billion)
  26. Gabapentin Market For Oral Solution, By Region, 2023-2033 ($ Billion)
  27. Gabapentin Market Segmentation, By Application
  28. Gabapentin Market For Epilepsy, By Region, 2023-2033 ($ Billion)
  29. Gabapentin Market For Neuropathic Pain, By Region, 2023-2033 ($ Billion)
  30. Gabapentin Market For Restless Legs Syndrome, By Region, 2023-2033 ($ Billion)
  31. Gabapentin Market For Others, By Region, 2023-2033 ($ Billion)
  32. GLENMARK PHARMACEUTICALS LTD.: Net Sales, 2023-2033 ($ Billion)
  33. GLENMARK PHARMACEUTICALS LTD.: Revenue Share, By Segment, 2023 (%)
  34. GLENMARK PHARMACEUTICALS LTD.: Revenue Share, By Region, 2023 (%)
  35. Arbor Pharmaceuticals, LLC: Net Sales, 2023-2033 ($ Billion)
  36. Arbor Pharmaceuticals, LLC: Revenue Share, By Segment, 2023 (%)
  37. Arbor Pharmaceuticals, LLC: Revenue Share, By Region, 2023 (%)
  38. Sun Pharmaceutical Industries Ltd.: Net Sales, 2023-2033 ($ Billion)
  39. Sun Pharmaceutical Industries Ltd.: Revenue Share, By Segment, 2023 (%)
  40. Sun Pharmaceutical Industries Ltd.: Revenue Share, By Region, 2023 (%)
  41. Ascend Laboratories LLC: Net Sales, 2023-2033 ($ Billion)
  42. Ascend Laboratories LLC: Revenue Share, By Segment, 2023 (%)
  43. Ascend Laboratories LLC: Revenue Share, By Region, 2023 (%)
  44. B.P. Pharma: Net Sales, 2023-2033 ($ Billion)
  45. B.P. Pharma: Revenue Share, By Segment, 2023 (%)
  46. B.P. Pharma: Revenue Share, By Region, 2023 (%)
  47. Zydus Lifesciences: Net Sales, 2023-2033 ($ Billion)
  48. Zydus Lifesciences: Revenue Share, By Segment, 2023 (%)
  49. Zydus Lifesciences: Revenue Share, By Region, 2023 (%)
  50. Teva Pharmaceutical Industries Ltd: Net Sales, 2023-2033 ($ Billion)
  51. Teva Pharmaceutical Industries Ltd: Revenue Share, By Segment, 2023 (%)
  52. Teva Pharmaceutical Industries Ltd: Revenue Share, By Region, 2023 (%)
  53. Amneal Pharmaceuticals LLC.: Net Sales, 2023-2033 ($ Billion)
  54. Amneal Pharmaceuticals LLC.: Revenue Share, By Segment, 2023 (%)
  55. Amneal Pharmaceuticals LLC.: Revenue Share, By Region, 2023 (%)
  56. Cipla.: Net Sales, 2023-2033 ($ Billion)
  57. Cipla.: Revenue Share, By Segment, 2023 (%)
  58. Cipla.: Revenue Share, By Region, 2023 (%)
  59. Apotex Inc.: Net Sales, 2023-2033 ($ Billion)
  60. Apotex Inc.: Revenue Share, By Segment, 2023 (%)
  61. Apotex Inc.: Revenue Share, By Region, 2023 (%)
  62. Assertio Holdings, Inc.: Net Sales, 2023-2033 ($ Billion)
  63. Assertio Holdings, Inc.: Revenue Share, By Segment, 2023 (%)
  64. Assertio Holdings, Inc.: Revenue Share, By Region, 2023 (%)
  65. Aurobindo Pharma: Net Sales, 2023-2033 ($ Billion)
  66. Aurobindo Pharma: Revenue Share, By Segment, 2023 (%)
  67. Aurobindo Pharma: Revenue Share, By Region, 2023 (%)
  68. Pfizer Inc.: Net Sales, 2023-2033 ($ Billion)
  69. Pfizer Inc.: Revenue Share, By Segment, 2023 (%)
  70. Pfizer Inc.: Revenue Share, By Region, 2023 (%)
  71. Others: Net Sales, 2023-2033 ($ Billion)
  72. Others: Revenue Share, By Segment, 2023 (%)
  73. Others: Revenue Share, By Region, 2023 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2023
Tables & Figures:102
Pages:245
Countries covered:17
Companies covered::18
Forecast CAGR:5.16%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies